Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2005-02-08
2005-02-08
Chan, Christina (Department: 1644)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C530S300000, C530S328000, C530S350000, C514S012200, C514S016700
Reexamination Certificate
active
06852321
ABSTRACT:
The invention relates to an isolated nucleic acid molecule that encodes a protein that is effective to preserve progenitor cells, such as hematopoietic progenitor cells. The nucleic acid comprises a sequence defined by SEQ ID NO:1, a homolog thereof, or a fragment thereof. The encoded protein has an amino acid sequence that comprises a sequence defined by SEQ ID NO:2, a homolog thereof or a fragment thereof that contains an amino acid sequence TNNVLQVT. Methods of using the encoded protein for preserving progenitor cells in vitro, ex vivo, and in vivo are also described. The invention, therefore, include methods such as myeloablation therapies for cancer treatment wherein myeloid reconstitution is facilitated by means of the specified protein. Other therapeutic utilities are also enabled through the invention, for example, expanding progenitor cell populations ex vivo to increase chances of engraftation, improving conditions for transporting and storing progenitor cells, and facilitating gene therapy to treat and cure a broad range of life-threatening hematologic diseases.
REFERENCES:
patent: 4808611 (1989-02-01), Cosman
patent: 5186931 (1993-02-01), Kishimoto et al.
patent: 5472867 (1995-12-01), Kanz et al.
patent: 5545820 (1996-08-01), Gatehouse et al.
patent: 6084060 (2000-07-01), Moore
patent: 6110891 (2000-08-01), Pusztai et al.
patent: 6280724 (2001-08-01), Moore
patent: 1009418 (2002-03-01), None
patent: 0942741 (2002-12-01), None
patent: WO 95 00554 (1995-05-01), None
patent: WO 97 41224 (1997-06-01), None
patent: WO 98 25457 (1998-06-01), None
patent: WO 98 59038 (1998-12-01), None
Mikayama et al. PNAS, 1993. 90: 10056-10060.*
Ngo et al, in The Protein Folding Problem and Tertiary Structure Prediction, 1994. (ed.), Birkhauser, Boston, MA, pp. 433 and 492-495.*
ARAR, C. et al., “ERGIC-53, A Membrane Protein of the Endoplasmic Reticulum-Golgi Intermediate Compartment, is Identical to MR60, an Intracellular Mannose-Specific Lectin of Myelomonocytic Cells”, J. Biol. Chem. 270(8):3551-3553, 1995.
Colucci, G. et al., “cDNA cloning of FRIL, a lectin from Dolichos lablab, that preserves hematopoietic progenitors in suspension culture”, Proc. Natl. Acad. Sci. 96:646-650, 1999.
Guigon, M. et al., “Inhibitory peptides in hematopoiesis”, Exp. Hematology. 23: 477-481, 1995.
Lenfant, M., et al., “Inhibitor of Hematopoietic Pluripotent Stem Cell Proliferation: Purification and Determination of Its Structure”, National Academy of Science 86:779-782, 1989.
Moore, J.G. et al., “Preservation of Hematopoietic progenitors for prolonged periods in suspension cultures by Flk2/ftt3 receptor-interacting lectin (FRIL) a new lectin identified in red kidney beans”, Blood 90:P 428A, 1997 (39thannual meeting of the American Society of Hematology: San Diego, California, Dec. 5-9, 1997).
Stubbs, M.E. et al., “Production of Pea Lectin inEscherichia coli”, J. Biol. Chem. 261(14):6141-6144, 1986.
Van Eijsden, R.R. et al., “Mutational Analysis of Pea Lectin. Substitution of Asn125 for Asp in the Monosaccharide-Binding Site Eliminatesmannose/glucose-binding Activity”. Plant Mol Biol. Dec;20(6):1049-58, 1992.
Marfatia, S.M., et al., “Identification of the Protein 4.1 Binding Interface on Glycophorin C and p55, a Hmologue of theDrosophila discs-largeTumor Suppressor Protein”, The Journal of Biological Chemistry 270(2):715-719, 1995.
Moreno, J., et al., “A Lectin Gene Encodes the ∀-amylase Inhibitor of the Common Bean”, Proc. Natl. Acad. Sci 86:7885-7889, 1989.
Mosmann, T., “Rapid Colorimetric Assay for Cellular Growth and Survival: Application to Proliferation and Cytotoxicity Assays”, Journal of Immunological Methods 65:55-63, 1983.
Opdenakker, C., et al., “Cells Regulate the Activities of Cytokines by Glycosylation”, The FASEB Journal 9:453-457, 1995.
Pueyo, J.J. et al., “Degradation of Transport-Competent Destabilized Phaseolin with a Signal for Retention in the Endoplasmic Reticulum Occurs in the Vacuole”, Planta 196:586-596, 1995.
Shah, A.J., et al., “Flt3 Ligand Induces Proliferation of Quiescent Human Bone Marrow CD34+CD38 Cells and Maintains Progenitor Cells in Vitro”, Blood 87(9):3563-3570, 1996.
Sharon, N., et al., “Lectins as Cell Recognition Molecules”, Science 246:227-234, 1989.
Small, D., et al., STK-1, the Human Hmolog of Flk-2/Flt-3, is Selectively Expressed in CD34+Human Bone Marrow Cells and is Involved in the Proliferation of Early Progenitor/Stem Cells Proc. Natl. Acad. Sci. 91:459-463, 1994.
Tessler, S., et al., “Heparin Modulates the Interaction of VEGF165with Soluble and Cell Associatedflk-1Receptors”, The Journal of Biological Chemistry 269(17):12456-12461, 1994.
Turhan, A.G., et al., “Clonal Hematopoiesis Demonstrated by X-Linked DNA Polymorphisms After Allogeneic Bone Marrow Transplantation”, The New England Journal of Medicine 320(25):1665-1661, 1989.
Van Damme, E.J., et al, Molecular Cloning of the Bark and Seed Lectins from the Japanese Pagoda Tree (Sophora Japonica) Plant Mol Biol. Feb;33(3):523-36. 1997.
Young, J.C., et al., “Retention of Quiescent Hematopoietic Cells with High Proliferative Potential During Ex Vivo Stem Cell Culture”, Blood 87(2):545-556, 1996.
Zipori, D., “Regulation of Hemopoiesis by Cytokines that Restrict Options for Growth and Differentiation”, Cancer Cells 2(7):205-211, 1990.
Zipori, D., “The Renewal and Differentiation of Hemopoietic Stem Cells”, The FASEB Journal 6:2691-2697,.
Altabella, T., et al., “Tobacco Plants Transformed with the Bean ∀ai Gene Express as Inhibitor of Insect ∀-Amylase in Their Seeds”, Plant Physiol. 93:805-810, 1990.
An, G., et al., “Binary Vectors”, Plant Molecular Biology Manual M3:1-19, 1998.
Barondes, S.H., et al., “Bifunctional Properties of Lectins: Lectins Redefined”, Trends in Biochemical Sciences 13:480-482, 1988.
Berardi, A.C., et al., “Functional Isolation and Characterization of Human Hematopoietic Stem Cells”, Science 267:104-108, 1995.
Borge, O.J., et al., “Thrombopoietin, But Not Erythropoietin Promotes Viability and inhibits Apoptosis of Multipotent Murine Hematopoietic Progenitor Cells In Vitro”, Blood 88(8):2859-2870, 1996.
Dexter, et al., “The Structure of the Hemopoietic System”, Cell Biol. 3:423-441, 1987.
Dosil, M., et al, “Mitogenic Signalling and Substrate Specificity of the Flk2/Flt3 Receptor Tyrosine Kinase in Fibroblasts and Interleukin 3-Dependent Hematopoietic Cells”, Molecular and Cellular Biolog. 13(10):6572-6586, 1993.
Dwek, R.A., “Glycobiology: More Functions for Oligosaccharides”, Science 269:1234-1235, 1995.
Gabius, H.J. “Non-Carbohydrate Binding Partners/Domains of Animal Lectins”, Int. J. Biochem. 26(4):469-477, 1994.
Gowda, L.R., et al., “The Complete Primary Structure of a Unique Mannose/Glucose-Specific Lectin from Field Bean”, The Journal of Biological Chemistry 269(29):18789-18793, 1994.
Hao, Q.L., et al., “Extended Long-Term Culture Reveals a Highly Quiescent and Primitive Human Hematopoietic Progenitor Population”, Blood 88(9):3306-3313, 1996.
Higgins, T.J.V., et al., “The Sequence of Pea Vicilin Gene and Its Expression in Transgenic Tobacco Plants”, Plant Molecular Biology 11:683-695, 1988.
Hoffman, L.M., et al., “Molecular Cloning ofPhaseolus VulgarisLectin mRNA and Use of cDNA as a Probe to Estimate Lectin Transcript Levels in Various Tissues”, Nucleic Acids Research 10(23):7820-7829, 1982.
Kuby, J.Immunology, W.H. Freeman & Co. NY, p. 95, 1992.
Kuriyama, M., et al., “Identification of AF-6 and Canoe as Putative Targets for Ras”, The Journal of Biological Chemistry 271(2):607-610, 1996.
Chrispeels Maarten J.
Colucci M. Gabriella
Moore Jeffrey G.
Belyavskyi Michail A
Chan Christina
ImClone Systems Incorporated
Regents of the University of California
Wilmer Cutler Pickering Hale and Dorr LLP
LandOfFree
Lectin-derived progenitor cell preservation factor and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Lectin-derived progenitor cell preservation factor and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lectin-derived progenitor cell preservation factor and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3461381